Existing wound infection treatments mainly rely on antibiotics that are inefficient towards drug-resistant bacteria and silver-based wound dressings that often cause skin irritation, delay wound healing, and inactivate bacteria only partially, leading to reoccurring infections and amputations.
Bacterial wound infections cause 10 million amputations every year.
Nanordica Medical has invented and patented nanotechnology that provides 8 times better treatment of infected wounds compared to the standard of care. Efficiency was confirmed by the North Estonia Medical Centre.
Nanordica Medical nanotechnology can be used to manufacture a wide range of antibacterial products like wound dressings, sprays, creams, catheters, or surface coatings.
As the first product, we developed advanced antibacterial wound dressing. We completed preclinical studies and started a pilot clinical study on patients with diabetic foot ulcers in the largest Estonian hospital.
